(Q36456017)

14 August 2017

1 reference

title

Non-viral vectors for cancer therapy (English)

1 reference

14 August 2017

Yasufumi Kaneda

1

1 reference

14 August 2017

Yasuhiko Tabata

series ordinal

2

1 reference

14 August 2017

publication date

1 May 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

97

1 reference

14 August 2017

issue

5

1 reference

14 August 2017

page(s)

348-354

1 reference

Nonviral gene therapy: promises and challenges

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Endosomes, lysosomes: their implication in gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Enhanced cationic liposome-mediated transfection using the DNA-binding peptide mu (mu) from the adenovirus core

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Use of liposomal anthracyclines in Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Cellular and molecular barriers to gene transfer by a cationic lipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Gene transfer with lipospermines and polyethylenimines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Targeted drug delivery via the folate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Cell-specific delivery of genes with glycosylated carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

DNA delivery from polymer matrices for tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

PEGylation enhances tumor targeting of plasmid DNA by an artificial cationized protein with repeated RGD sequences, Pronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Gene therapy progress and prospects: electroporation and other physical methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Gene therapy using HVJ-liposomes: the best of both worlds?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Eradication of hepatocellular carcinoma xenografts by radiolabelled, lipiodol-inducible gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

EBV replicon vector system enhances transgene expression in vivo: applications to cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

De novo methylation and expression of retroviral genomes during mouse embryogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Assembly of variant histones into chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Structural and sequence motifs of protein (histone) methylation enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Biocompatible polymer enhances the in vitro and in vivo transfection efficiency of HVJ envelope vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00189.X

10.1111/J.1349-7006.2006.00189.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference